World Journal of Gastroenterology - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

JOURNAL HOME

Homepage

Online Submission

Number of total visits: 30613130

Number of visits today: 6987

Number of downloads: 13018426

MEMBERSHIP

BPG JOURNALS

Cited by in F6Publishing

For:	Raimondi F, Inoue A, Kadji FMN, Shuai N, Gonzalez JC, Singh G, de la Vega AA, Sotillo R, Fischer B, Aoki J, Gutkind JS, Russell RB. Rare, functional, somatic variants in gene families linked to cancer genes: GPCR signaling as a paradigm. Oncogene 2019;38:6491-506. [PMID: 31337866 DOI: 10.1038/s41388-019-0895-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]

For:

Raimondi F, Inoue A, Kadji FMN, Shuai N, Gonzalez JC, Singh G, de la Vega AA, Sotillo R, Fischer B, Aoki J, Gutkind JS, Russell RB. Rare, functional, somatic variants in gene families linked to cancer genes: GPCR signaling as a paradigm. Oncogene 2019;38:6491-506. [PMID: 31337866 DOI: 10.1038/s41388-019-0895-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]

Number	Citing Articles
1	Ramms DJ, Raimondi F, Arang N, Herberg FW, Taylor SS, Gutkind JS. Gαs-Protein Kinase A (PKA) Pathway Signalopathies: The Emerging Genetic Landscape and Therapeutic Potential of Human Diseases Driven by Aberrant Gαs-PKA Signaling. Pharmacol Rev 2021;73:155-97. [PMID: 34663687 DOI: 10.1124/pharmrev.120.000269] [Reference Citation Analysis]
2	Wu V, Yeerna H, Nohata N, Chiou J, Harismendy O, Raimondi F, Inoue A, Russell RB, Tamayo P, Gutkind JS. Illuminating the Onco-GPCRome: Novel G protein-coupled receptor-driven oncocrine networks and targets for cancer immunotherapy. J Biol Chem 2019;294:11062-86. [PMID: 31171722 DOI: 10.1074/jbc.REV119.005601] [Cited by in Crossref: 56] [Cited by in F6Publishing: 35] [Article Influence: 18.7] [Reference Citation Analysis]
3	Huh E, Gallion J, Agosto MA, Wright SJ, Wensel TG, Lichtarge O. Recurrent high-impact mutations at cognate structural positions in class A G protein-coupled receptors expressed in tumors. Proc Natl Acad Sci U S A 2021;118:e2113373118. [PMID: 34916293 DOI: 10.1073/pnas.2113373118] [Reference Citation Analysis]
4	Cunningham R, Hansen CG. The Hippo pathway in cancer: YAP/TAZ and TEAD as therapeutic targets in cancer. Clin Sci (Lond) 2022;136:197-222. [PMID: 35119068 DOI: 10.1042/CS20201474] [Reference Citation Analysis]
5	Arang N, Gutkind JS. G Protein-Coupled receptors and heterotrimeric G proteins as cancer drivers. FEBS Lett 2020;594:4201-32. [PMID: 33270228 DOI: 10.1002/1873-3468.14017] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 9.0] [Reference Citation Analysis]
6	Diwan GD, Carlos Gonzalez-Sanchez J, Apic G, Russell RB. Next generation protein structure predictions and genetic variant interpretation. J Mol Biol 2021;:167180. [PMID: 34358547 DOI: 10.1016/j.jmb.2021.167180] [Reference Citation Analysis]